Akèy › Atak kè › Tennessee › Knoxville
Etid klinik pou Atak kè nan Knoxville, TN
4 etid pou Atak kè ap chèche patisipan nan sit nan ak bò kote Knoxville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Cardiovascular Res of Knoxville LLC, Powell · 8 mi lwen
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Ap rekriteFaz 3
- Parkway Cardiology Associates, Oak Ridge · 20 mi lwen
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Ap rekrite
- University of Tennessee Medical Center, Knoxville
Etid Atak kè nan lòt vil
- New York City, NY7 etid
- Dallas, TX6 etid
- Boston, MA6 etid
- Rochester, MN6 etid
- Hartford, CT4 etid
- Boca Raton, FL4 etid
- Nashville, TN4 etid
- Los Angeles, CA4 etid
- Houston, TX4 etid
- Detroit, MI4 etid
- Greensboro, NC4 etid
- Minneapolis, MN3 etid
Lòt etid nan Knoxville
- Kansè Poumon ki pa ti selil14 etid
- Obèsite10 etid
- Kansè poumon10 etid
- Kansè nan tete9 etid
- Kansè (tout kalite)8 etid
- Sipwa7 etid
- Ensifizyans kadyak7 etid
- Kansè Metastatik7 etid
- Maladi kadyovaskilè6 etid
- Melanom5 etid
- Dyabèt Tip 25 etid
- Hypertension artérielle5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.